Tag: patients

Many Patients Withhold Information From Clinicians

TUESDAY, Dec. 4, 2018 — Many patients intentionally withhold information from clinicians, according to a study published online Nov. 30 in JAMA Network Open. Andrea Gurmankin Levy, Ph.D., from Middlesex Community College in Middletown, Connecticut, and colleagues recruited two national nonprobability samples (Amazon’s Mechanical Turk [MTurk], 2,096 respondents, and Survey Sampling International [SSI], 3,011 respondents)

Older, frail heart attack patients at greater risk of bleeding

Many older patients who are considered frail by medical standards receive anticoagulants (blood thinners) and undergo cardiac catheterization during a heart attack. While these treatments can be helpful, they also can cause major bleeding, and frailty is an important bleeding risk factor according to a study published today in in JACC: Cardiovascular Interventions. The research

Scientists tell new facts about depression

Scientists have brought new arguments in support of the hypothesis that individuals with depression tend to be more active in neural systems accountable for ideas about their and themselves group of friends. The findings from the study are printed around the pages from the Journal of Affective Disorders. Based on gazeta.ru, scientists stated that the

Most patients with cystic fibrosis may receive insufficient antibiotics to fight lung infections

The majority of patients with cystic fibrosis may not achieve blood concentrations of antibiotics sufficiently high enough to effectively fight bacteria responsible for pulmonary exacerbations, leading to worsening pulmonary function, indicates a study led by researchers at Children’s National Health System. Additionally, the study findings show that it’s impossible to predict solely from dosing regimens

Patients at risk of coverage denial

Researchers at Brigham and Women’s Hospital analyzed a national sample of Emergency Department visits between 2011-15 to determine what proportion of them could be denied coverage if commercial insurers across the U.S. adopted the policy of a large national insurer, Anthem, Inc., to potentially deny coverage, after the visit, based on ED discharge diagnoses. Researchers

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

For the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal, metastatic cancer, according to a clinical study published in Breast Cancer Research in October. The researchers found that when cells from a breast cancer patient’s original tumor

The man with ‘mushrooms’ in his ear

The man with ‘MUSHROOMS’ in his ear: Patient’s fungal infection causes ‘a forest’ of black blobs of mould to grow inside his ear canal The man in Vietnam reportedly experienced pain and itching in his ear At hospital doctors investigated and found a fungal infection in the ear canal  A UK expert says the fungi

Just one-third of Chinese acute coronary syndrome patients receive rehabilitation guidance

Just one-third of Chinese patients with acute coronary syndromes including heart attack receive cardiac rehabilitation guidance before discharge from hospital, according to research presented at the 29th Great Wall International Congress of Cardiology (GW-ICC). Only one in ten receive personalised advice. GW-ICC 2018 is being held 11 to 14 October in Beijing, China. Visiting experts

New risk test for sepsis for heart patients

Nearly one in four deaths in people with heart failure are caused by sepsis, according to new research. Now scientists from the University of Leeds, who are funded by the British Heart Foundation, have developed a ‘risk profile’ to identify patients who are most at risk, often years before they become ill. The researchers hope

New cancer vaccine shows early promise for patients with HER2-positive cancers

Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3. Among 11